Global TravEpiNet: A national consortium of clinics providing care to international travelers-analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011

Regina C. Larocque; Sowmya R. Rao; Jennifer Lee; Vernon Ansdell; Johnnie A. Yates; Brian S. Schwartz; Mark Knouse; John Cahill; Stefan Hagmann; Joseph Vinetz; Bradley A. Connor; Jeffery A. Goad; Alawode Oladele; Salvador Alvarez; William Stauffer; Patricia Walker; Phyllis Kozarsky; Carlos Franco-Paredes; Roberta Dismukes; Jessica Rosen; Noreen A. Hynes; Frederique Jacquerioz; Susan McLellan; Devon Hale; Theresa Sofarelli; David Schoenfeld; Nina Marano; Gary Brunette; Emily S. Jentes; Emad Yanni; Mark J. Sotir; Edward T. Ryan

doi:10.1093/cid/cir839

Global TravEpiNet: A national consortium of clinics providing care to international travelers-analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011

Regina C. Larocque
, Sowmya R. Rao
, Jennifer Lee
, Vernon Ansdell
, Johnnie A. Yates
, Brian S. Schwartz
, Mark Knouse
, John Cahill
, Stefan Hagmann
, Joseph Vinetz
, Bradley A. Connor
, Jeffery A. Goad
, Alawode Oladele
, Salvador Alvarez
, William Stauffer
, Patricia Walker
, Phyllis Kozarsky
, Carlos Franco-Paredes
, Roberta Dismukes
, Jessica Rosen

Noreen A. Hynes, Frederique Jacquerioz, Susan McLellan, Devon Hale, Theresa Sofarelli, David Schoenfeld, Nina Marano, Gary Brunette, Emily S. Jentes, Emad Yanni, Mark J. Sotir, Edward T. Ryan

Massachusetts General Hospital
Harvard Medical School
Northwestern Memorial Hospital
Kaiser Permanente
University of California San Francisco Center for Tuberculosis
Lehigh Valley Health Network
Travel and Immunization Center
Albert Einstein College of Medicine
Department of Medicine
Cornell University
University of Southern California
DeKalb County Board of Health Travel Services-DeKalb East
Mayo Clinic in Jacksonville, Florida
HealthPartners
Emory University
Georgetown University
Johns Hopkins University School of Medicine
Tulane University
University of Utah School of Medicine
Centers for Disease Control and Prevention

Research output: Contribution to journal › Article › peer-review

119 Scopus citations

Abstract

Background. International travel poses a risk of destination-specific illness and may contribute to the global spread of infectious diseases. Despite this, little is known about the health characteristics and pretravel healthcare of US international travelers, particularly those at higher risk of travel-associated illness. Methods. We formed a national consortium (Global TravEpiNet) of 18 US clinics registered to administer yellow fever vaccination. We collected data regarding demographic and health characteristics, destinations, purpose of travel, and pretravel healthcare from 13235 international travelers who sought pretravel consultation at these sites from January 2009 through January 2011.Results.The destinations and itineraries of Global TravEpiNet travelers differed from those of the overall population of US international travelers. The majority of Global TravEpiNet travelers were visiting low-or lower-middle-income countries, and Africa was the most frequently visited region. Seventy-five percent of travelers were visiting malaria-endemic countries, and 38% were visiting countries endemic for yellow fever. Fifty-nine percent of travelers reported ≥1 medical condition. Atovaquone/proguanil was the most commonly prescribed antimalarial drug, and most travelers received an antibiotic for self-treatment of travelers' diarrhea. Hepatitis A and typhoid were the most frequently administered vaccines. Conclusions. Data from Global TravEpiNet provide insight into the characteristics and pretravel healthcare of US international travelers who are at increased risk of travel-associated illness due to itinerary, purpose of travel, or existing medical conditions. Improved understanding of this epidemiologically significant population may help target risk-reduction strategies and interventions to limit the spread of infections related to global travel.

Original language	English
Pages (from-to)	455-462
Number of pages	8
Journal	Clinical Infectious Diseases
Volume	54
Issue number	4
DOIs	https://doi.org/10.1093/cid/cir839
State	Published - 15 Feb 2012
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1093/cid/cir839

Fingerprint

Dive into the research topics of 'Global TravEpiNet: A national consortium of clinics providing care to international travelers-analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011'. Together they form a unique fingerprint.

Cite this

Larocque, R. C., Rao, S. R., Lee, J., Ansdell, V., Yates, J. A., Schwartz, B. S., Knouse, M., Cahill, J., Hagmann, S., Vinetz, J., Connor, B. A., Goad, J. A., Oladele, A., Alvarez, S., Stauffer, W., Walker, P., Kozarsky, P., Franco-Paredes, C., Dismukes, R., ... Ryan, E. T. (2012). Global TravEpiNet: A national consortium of clinics providing care to international travelers-analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011. Clinical Infectious Diseases, 54(4), 455-462. https://doi.org/10.1093/cid/cir839

@article{f86afbe8c55d48ab9abb5934e6daa348,

title = "Global TravEpiNet: A national consortium of clinics providing care to international travelers-analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011",

abstract = "Background. International travel poses a risk of destination-specific illness and may contribute to the global spread of infectious diseases. Despite this, little is known about the health characteristics and pretravel healthcare of US international travelers, particularly those at higher risk of travel-associated illness. Methods. We formed a national consortium (Global TravEpiNet) of 18 US clinics registered to administer yellow fever vaccination. We collected data regarding demographic and health characteristics, destinations, purpose of travel, and pretravel healthcare from 13235 international travelers who sought pretravel consultation at these sites from January 2009 through January 2011.Results.The destinations and itineraries of Global TravEpiNet travelers differed from those of the overall population of US international travelers. The majority of Global TravEpiNet travelers were visiting low-or lower-middle-income countries, and Africa was the most frequently visited region. Seventy-five percent of travelers were visiting malaria-endemic countries, and 38\% were visiting countries endemic for yellow fever. Fifty-nine percent of travelers reported ≥1 medical condition. Atovaquone/proguanil was the most commonly prescribed antimalarial drug, and most travelers received an antibiotic for self-treatment of travelers' diarrhea. Hepatitis A and typhoid were the most frequently administered vaccines. Conclusions. Data from Global TravEpiNet provide insight into the characteristics and pretravel healthcare of US international travelers who are at increased risk of travel-associated illness due to itinerary, purpose of travel, or existing medical conditions. Improved understanding of this epidemiologically significant population may help target risk-reduction strategies and interventions to limit the spread of infections related to global travel.",

author = "Larocque, \{Regina C.\} and Rao, \{Sowmya R.\} and Jennifer Lee and Vernon Ansdell and Yates, \{Johnnie A.\} and Schwartz, \{Brian S.\} and Mark Knouse and John Cahill and Stefan Hagmann and Joseph Vinetz and Connor, \{Bradley A.\} and Goad, \{Jeffery A.\} and Alawode Oladele and Salvador Alvarez and William Stauffer and Patricia Walker and Phyllis Kozarsky and Carlos Franco-Paredes and Roberta Dismukes and Jessica Rosen and Hynes, \{Noreen A.\} and Frederique Jacquerioz and Susan McLellan and Devon Hale and Theresa Sofarelli and David Schoenfeld and Nina Marano and Gary Brunette and Jentes, \{Emily S.\} and Emad Yanni and Sotir, \{Mark J.\} and Ryan, \{Edward T.\}",

year = "2012",

month = feb,

day = "15",

doi = "10.1093/cid/cir839",

language = "Ingl{\'e}s",

volume = "54",

pages = "455--462",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

number = "4",

}

Larocque, RC, Rao, SR, Lee, J, Ansdell, V, Yates, JA, Schwartz, BS, Knouse, M, Cahill, J, Hagmann, S, Vinetz, J, Connor, BA, Goad, JA, Oladele, A, Alvarez, S, Stauffer, W, Walker, P, Kozarsky, P, Franco-Paredes, C, Dismukes, R, Rosen, J, Hynes, NA, Jacquerioz, F, McLellan, S, Hale, D, Sofarelli, T, Schoenfeld, D, Marano, N, Brunette, G, Jentes, ES, Yanni, E, Sotir, MJ & Ryan, ET 2012, 'Global TravEpiNet: A national consortium of clinics providing care to international travelers-analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011', Clinical Infectious Diseases, vol. 54, no. 4, pp. 455-462. https://doi.org/10.1093/cid/cir839

Global TravEpiNet: A national consortium of clinics providing care to international travelers-analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011. / Larocque, Regina C.; Rao, Sowmya R.; Lee, Jennifer et al.
In: Clinical Infectious Diseases, Vol. 54, No. 4, 15.02.2012, p. 455-462.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Global TravEpiNet

T2 - A national consortium of clinics providing care to international travelers-analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011

AU - Larocque, Regina C.

AU - Rao, Sowmya R.

AU - Lee, Jennifer

AU - Ansdell, Vernon

AU - Yates, Johnnie A.

AU - Schwartz, Brian S.

AU - Knouse, Mark

AU - Cahill, John

AU - Hagmann, Stefan

AU - Vinetz, Joseph

AU - Connor, Bradley A.

AU - Goad, Jeffery A.

AU - Oladele, Alawode

AU - Alvarez, Salvador

AU - Stauffer, William

AU - Walker, Patricia

AU - Kozarsky, Phyllis

AU - Franco-Paredes, Carlos

AU - Dismukes, Roberta

AU - Rosen, Jessica

AU - Hynes, Noreen A.

AU - Jacquerioz, Frederique

AU - McLellan, Susan

AU - Hale, Devon

AU - Sofarelli, Theresa

AU - Schoenfeld, David

AU - Marano, Nina

AU - Brunette, Gary

AU - Jentes, Emily S.

AU - Yanni, Emad

AU - Sotir, Mark J.

AU - Ryan, Edward T.

PY - 2012/2/15

Y1 - 2012/2/15

N2 - Background. International travel poses a risk of destination-specific illness and may contribute to the global spread of infectious diseases. Despite this, little is known about the health characteristics and pretravel healthcare of US international travelers, particularly those at higher risk of travel-associated illness. Methods. We formed a national consortium (Global TravEpiNet) of 18 US clinics registered to administer yellow fever vaccination. We collected data regarding demographic and health characteristics, destinations, purpose of travel, and pretravel healthcare from 13235 international travelers who sought pretravel consultation at these sites from January 2009 through January 2011.Results.The destinations and itineraries of Global TravEpiNet travelers differed from those of the overall population of US international travelers. The majority of Global TravEpiNet travelers were visiting low-or lower-middle-income countries, and Africa was the most frequently visited region. Seventy-five percent of travelers were visiting malaria-endemic countries, and 38% were visiting countries endemic for yellow fever. Fifty-nine percent of travelers reported ≥1 medical condition. Atovaquone/proguanil was the most commonly prescribed antimalarial drug, and most travelers received an antibiotic for self-treatment of travelers' diarrhea. Hepatitis A and typhoid were the most frequently administered vaccines. Conclusions. Data from Global TravEpiNet provide insight into the characteristics and pretravel healthcare of US international travelers who are at increased risk of travel-associated illness due to itinerary, purpose of travel, or existing medical conditions. Improved understanding of this epidemiologically significant population may help target risk-reduction strategies and interventions to limit the spread of infections related to global travel.

AB - Background. International travel poses a risk of destination-specific illness and may contribute to the global spread of infectious diseases. Despite this, little is known about the health characteristics and pretravel healthcare of US international travelers, particularly those at higher risk of travel-associated illness. Methods. We formed a national consortium (Global TravEpiNet) of 18 US clinics registered to administer yellow fever vaccination. We collected data regarding demographic and health characteristics, destinations, purpose of travel, and pretravel healthcare from 13235 international travelers who sought pretravel consultation at these sites from January 2009 through January 2011.Results.The destinations and itineraries of Global TravEpiNet travelers differed from those of the overall population of US international travelers. The majority of Global TravEpiNet travelers were visiting low-or lower-middle-income countries, and Africa was the most frequently visited region. Seventy-five percent of travelers were visiting malaria-endemic countries, and 38% were visiting countries endemic for yellow fever. Fifty-nine percent of travelers reported ≥1 medical condition. Atovaquone/proguanil was the most commonly prescribed antimalarial drug, and most travelers received an antibiotic for self-treatment of travelers' diarrhea. Hepatitis A and typhoid were the most frequently administered vaccines. Conclusions. Data from Global TravEpiNet provide insight into the characteristics and pretravel healthcare of US international travelers who are at increased risk of travel-associated illness due to itinerary, purpose of travel, or existing medical conditions. Improved understanding of this epidemiologically significant population may help target risk-reduction strategies and interventions to limit the spread of infections related to global travel.

UR - https://www.scopus.com/pages/publications/84863068669

U2 - 10.1093/cid/cir839

DO - 10.1093/cid/cir839

M3 - Artículo

C2 - 22144534

AN - SCOPUS:84863068669

SN - 1058-4838

VL - 54

SP - 455

EP - 462

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 4

ER -

Larocque RC, Rao SR, Lee J, Ansdell V, Yates JA, Schwartz BS et al. Global TravEpiNet: A national consortium of clinics providing care to international travelers-analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011. Clinical Infectious Diseases. 2012 Feb 15;54(4):455-462. doi: 10.1093/cid/cir839

Global TravEpiNet: A national consortium of clinics providing care to international travelers-analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this